CDH1 and prostate carcinoma: Sequence variants in several genes, such as SRD5A (steroid-5-alpha-reductase alpha polypeptide) [4], androgen receptor [5], estrogen receptor-β [6], E-cadherin [7], and toll-like receptors [8–10], have been associated with prostate cancer.